(Q33804685)

29 July 2017

1 reference

title

Is there a role for intensive therapy in breast cancer? (English)

1 reference

29 July 2017

Bergh J

1

1 reference

29 July 2017

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

38 Suppl 13

1 reference

29 July 2017

37-46

1 reference

Bone marrow autotransplantation for solid tumors--prospects

29 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Dose intensity in patients with metastatic breast cancer--time for novel thoughts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Dose-response effect of adjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Patterns of failure following bone marrow transplantation for metastatic breast cancer: the role of consolidative local therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

High-dose therapy with autologous bone marrow stem cell support in primary and metastatic human breast cancer. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Diagnosis of minimal residual disease in bone marrow and blood in cancer patients--methods and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high-dose chemotherapy and autotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418699432752

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

21 January 2018

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1200/JCO.1995.13.10.2483

Identifiers

DOI

10.1080/028418699432752

1 reference

29 July 2017

1 reference

PubMed ID

10612495